Detalhe da pesquisa
1.
Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer.
Nature
; 603(7903): 942-948, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35322232
2.
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer.
Nature
; 600(7890): 727-730, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34912120
3.
Neoadjuvant and adjuvant pembrolizumab plus chemotherapy in locally advanced gastric or gastro-oesophageal cancer (KEYNOTE-585): an interim analysis of the multicentre, double-blind, randomised phase 3 study.
Lancet Oncol
; 25(2): 212-224, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134948
4.
Pembrolizumab plus trastuzumab and chemotherapy for HER2-positive gastric or gastro-oesophageal junction adenocarcinoma: interim analyses from the phase 3 KEYNOTE-811 randomised placebo-controlled trial.
Lancet
; 402(10418): 2197-2208, 2023 12 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37871604
5.
Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial.
Lancet Oncol
; 24(11): 1181-1195, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875143
6.
A plain language summary of the CheckMate 649 study: nivolumab in combination with chemotherapy compared to chemotherapy alone for untreated advanced or metastatic cancer of the stomach or esophagus.
Future Oncol
; 19(11): 739-752, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36919706
7.
First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial.
Lancet
; 398(10294): 27-40, 2021 07 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34102137
8.
Olaparib with or without bevacizumab versus bevacizumab plus a fluoropyrimidine as maintenance therapy in advanced colorectal cancer: The randomized phase 3 LYNK-003 study.
Eur J Cancer
; 205: 114036, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38749110
9.
Pembrolizumab Plus Olaparib for Patients With Previously Treated and Biomarker-Unselected Metastatic Castration-Resistant Prostate Cancer: The Randomized, Open-Label, Phase III KEYLYNK-010 Trial.
J Clin Oncol
; 41(22): 3839-3850, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290035
10.
High frequency of digital eye strain and dry eye disease in teleworkers during the coronavirus disease (2019) pandemic.
Int J Occup Saf Ergon
; 28(3): 1787-1792, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34082647
11.
Dry Eye and Visual Display Terminal-Related Symptoms among University Students during the Coronavirus Disease Pandemic.
Ophthalmic Epidemiol
; 29(3): 245-251, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34251964
12.
Estudio CURIE-2017: Nociones de los estudiantes del internado rotativo de medicina del Hospital Carlos Andrade Marín (Quito) con respecto al uso y aplicación de estudios imagenológicos / CURIE-2017 Study: Notions of the students of the rotating medical internship of the Carlos Andrade Marín Hospital (Quito) regarding the use and application of general imaging studies
Rev. de la Fed. Ecuat. de Soc. de Radiol
; 11(2): 31-35, dic. 2018.
Artigo
em Espanhol
| LILACS | ID: biblio-1005076
13.
Plantas frecuentemente utilizadas en zonas rurales de la Región Amazónica centro occidental de Ecuador / Plants frequently used in rural areas of the Amazon Region, western central Ecuador
Innova Research Journal
; 2(6): 9-21, 2017.
Artigo
em Espanhol
| LILACS, MTYCI | ID: biblio-910915